Cargando…

The synergy factor: a statistic to measure interactions in complex diseases

BACKGROUND: One challenge in understanding complex diseases lies in revealing the interactions between susceptibility factors, such as genetic polymorphisms and environmental exposures. There is thus a need to examine such interactions explicitly. A corollary is the need for an accessible method of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortina-Borja, Mario, Smith, A David, Combarros, Onofre, Lehmann, Donald J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706251/
https://www.ncbi.nlm.nih.gov/pubmed/19527493
http://dx.doi.org/10.1186/1756-0500-2-105
_version_ 1782169059798810624
author Cortina-Borja, Mario
Smith, A David
Combarros, Onofre
Lehmann, Donald J
author_facet Cortina-Borja, Mario
Smith, A David
Combarros, Onofre
Lehmann, Donald J
author_sort Cortina-Borja, Mario
collection PubMed
description BACKGROUND: One challenge in understanding complex diseases lies in revealing the interactions between susceptibility factors, such as genetic polymorphisms and environmental exposures. There is thus a need to examine such interactions explicitly. A corollary is the need for an accessible method of measuring both the size and the significance of interactions, which can be used by non-statisticians and with summarised, e.g. published data. The lack of such a readily available method has contributed to confusion in the field. FINDINGS: The synergy factor (SF) allows assessment of binary interactions in case-control studies. In this paper we describe its properties and its novel characteristics, e.g. in calculating the power to detect a synergistic effect and in its application to meta-analyses. We illustrate these functions with real examples in Alzheimer's disease, e.g. a meta-analysis of the potential interaction between a BACE1 polymorphism and APOE4: SF = 2.5, 95% confidence interval: 1.5–4.2; p = 0.0001. CONCLUSION: Synergy factors are easy to use and clear to interpret. Calculations may be performed through the Excel programmes provided within this article. Unlike logistic regression analysis, the method can be applied to datasets of any size, however small. It can be applied to primary or summarised data, e.g. published data. It can be used with any type of susceptibility factor, provided the data are dichotomised. Novel features include power estimation and meta-analysis.
format Text
id pubmed-2706251
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27062512009-07-07 The synergy factor: a statistic to measure interactions in complex diseases Cortina-Borja, Mario Smith, A David Combarros, Onofre Lehmann, Donald J BMC Res Notes Short Report BACKGROUND: One challenge in understanding complex diseases lies in revealing the interactions between susceptibility factors, such as genetic polymorphisms and environmental exposures. There is thus a need to examine such interactions explicitly. A corollary is the need for an accessible method of measuring both the size and the significance of interactions, which can be used by non-statisticians and with summarised, e.g. published data. The lack of such a readily available method has contributed to confusion in the field. FINDINGS: The synergy factor (SF) allows assessment of binary interactions in case-control studies. In this paper we describe its properties and its novel characteristics, e.g. in calculating the power to detect a synergistic effect and in its application to meta-analyses. We illustrate these functions with real examples in Alzheimer's disease, e.g. a meta-analysis of the potential interaction between a BACE1 polymorphism and APOE4: SF = 2.5, 95% confidence interval: 1.5–4.2; p = 0.0001. CONCLUSION: Synergy factors are easy to use and clear to interpret. Calculations may be performed through the Excel programmes provided within this article. Unlike logistic regression analysis, the method can be applied to datasets of any size, however small. It can be applied to primary or summarised data, e.g. published data. It can be used with any type of susceptibility factor, provided the data are dichotomised. Novel features include power estimation and meta-analysis. BioMed Central 2009-06-15 /pmc/articles/PMC2706251/ /pubmed/19527493 http://dx.doi.org/10.1186/1756-0500-2-105 Text en Copyright © 2009 Combarros et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Cortina-Borja, Mario
Smith, A David
Combarros, Onofre
Lehmann, Donald J
The synergy factor: a statistic to measure interactions in complex diseases
title The synergy factor: a statistic to measure interactions in complex diseases
title_full The synergy factor: a statistic to measure interactions in complex diseases
title_fullStr The synergy factor: a statistic to measure interactions in complex diseases
title_full_unstemmed The synergy factor: a statistic to measure interactions in complex diseases
title_short The synergy factor: a statistic to measure interactions in complex diseases
title_sort synergy factor: a statistic to measure interactions in complex diseases
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706251/
https://www.ncbi.nlm.nih.gov/pubmed/19527493
http://dx.doi.org/10.1186/1756-0500-2-105
work_keys_str_mv AT cortinaborjamario thesynergyfactorastatistictomeasureinteractionsincomplexdiseases
AT smithadavid thesynergyfactorastatistictomeasureinteractionsincomplexdiseases
AT combarrosonofre thesynergyfactorastatistictomeasureinteractionsincomplexdiseases
AT lehmanndonaldj thesynergyfactorastatistictomeasureinteractionsincomplexdiseases
AT cortinaborjamario synergyfactorastatistictomeasureinteractionsincomplexdiseases
AT smithadavid synergyfactorastatistictomeasureinteractionsincomplexdiseases
AT combarrosonofre synergyfactorastatistictomeasureinteractionsincomplexdiseases
AT lehmanndonaldj synergyfactorastatistictomeasureinteractionsincomplexdiseases